Chilton Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Chilton Capital Management's OGN Position: Q1 2026 in Review
Chilton Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 510 shares — an estimated $3.66K sold.
Chilton Capital Management first reported a position in OGN in Q4 2021 and held it in 14 quarters. The position peaked at $81K in Q4 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Chilton Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
- Chilton Capital Management sold 510 Organon & Co shares in Q1 2026, an estimated $3.66K.
- Chilton Capital Management first reported a position in Organon & Co in Q4 2021 and held it in 14 quarters.
- Chilton Capital Management's Organon & Co position peaked at $81K in Q4 2021.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.